Skip to main content

Health

6
Pipeline Programs
8
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
5
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 7 programs with unclassified modality

Competitive Landscape

8 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
TolterodinePhase 21 trial
Active Trials
NCT00332137Completed36Est. Aug 2007
Medica Corp
Medica CorpMA - Bedford
1 program
1
Apixaban 5 mg Film-Coated TabletPhase 11 trial
Active Trials
NCT06817811Completed24Est. Jun 2021
Dexa Medica
Dexa MedicaIndonesia - Tangerang
1 program
1
Apixaban 5 mg Film-Coated TabletPhase 1
Otsuka
OtsukaJapan - Tokushima
1 program
1
BrexpiprazolePhase 1Small Molecule1 trial
Active Trials
NCT03734354Completed30Est. May 2020
Livzon Pharmaceutical
Livzon PharmaceuticalChina - Zhuhai
1 program
1
DBM-1152A Inhalation SolutionPhase 11 trial
Active Trials
NCT07447141Completed44Est. Apr 2024
Lumosa Therapeutics
Lumosa TherapeuticsTaiwan - Taipei
1 program
1
Dinalbuphine sebacatePhase 11 trial
Active Trials
NCT04256434Completed24Est. May 2020
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
No treatmentN/A1 trial
Active Trials
NCT01518270Completed179Est. Dec 2011
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Miconazole nitratePHASE_41 trial
Active Trials
NCT00194324Completed12Est. Oct 2004

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonMiconazole nitrate
PfizerTolterodine
Livzon PharmaceuticalDBM-1152A Inhalation Solution
Medica CorpApixaban 5 mg Film-Coated Tablet
Lumosa TherapeuticsDinalbuphine sebacate
OtsukaBrexpiprazole
AbbVieNo treatment

Clinical Trials (7)

Total enrollment: 349 patients across 7 trials

NCT00194324Johnson & JohnsonMiconazole nitrate

Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina

Start: Jul 2004Est. completion: Oct 200412 patients
Phase 4Completed
NCT00332137PfizerTolterodine

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

Start: Sep 2005Est. completion: Aug 200736 patients
Phase 2Completed
NCT07447141Livzon PharmaceuticalDBM-1152A Inhalation Solution

DBM-1152A Inhalation Solution in Chinese Healthy Subjects

Start: Dec 2023Est. completion: Apr 202444 patients
Phase 1Completed
NCT06817811Medica CorpApixaban 5 mg Film-Coated Tablet

Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet

Start: Apr 2021Est. completion: Jun 202124 patients
Phase 1Completed
NCT04256434Lumosa TherapeuticsDinalbuphine sebacate

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

Start: Jan 2020Est. completion: May 202024 patients
Phase 1Completed
NCT03734354OtsukaBrexpiprazole

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Start: Apr 2019Est. completion: May 202030 patients
Phase 1Completed
NCT01518270AbbVieNo treatment

Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women

Start: Dec 2011Est. completion: Dec 2011179 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.